Vanderbilt-Ingram Cancer Center director to assume new leadership role
Jennifer Pietenpol, PhD, director of Vanderbilt-Ingram Cancer Center, will step down from that position this summer to focus on a new combined leadership role.
Pietenpol will take over as chief scientific and strategy officer for Vanderbilt University Medical Center (VUMC) effective June 30.
Pietenpol will lead the organization’s scientific, technological and research strategy and operations. She also will work with the CEO and other senior leaders and officers to devise, execute and sustain strategic initiatives.
“It is exciting to have the opportunity to step into a new leadership role at VUMC and continue to advance our strategic directions and integrate research discoveries into the care of those we serve both within and beyond our ever-growing catchment area and, importantly, make a difference in the lives of people,” Pietenpol, who also serves as executive vice president for research for the medical center, said in a press release. “I look forward to welcoming a new director to take the lead for the next phase of Vanderbilt-Ingram Cancer Center’s trajectory and am eager for its bright future.”
Pietenpol has served as director of Vanderbilt-Ingram Cancer Center for 15 years.
“Dr. Pietenpol’s assuming these new responsibilities is a natural progression, allowing full advantage of the depth and breadth of her extensive institutional experience,” Jeff Balser, MD, PhD, president and CEO of Vanderbilt University Medical Center and dean of Vanderbilt University School of Medicine, said in the release. “Jennifer’s prior leadership involving such a broad range of transdisciplinary initiatives makes her ideally suited for these new roles. I look forward to her partnership as we continue the important work of designing and pursuing VUMC’s future.”
Read more about